Chapter 8 — Key Takeaways

What you should leave Chapter 8 with

1. Mechanism determines stereochemistry. The geometry of the transition state determines the stereochemistry of the product. Conversely, observed stereochemistry tells you the mechanism.

2. Three possible outcomes at a stereocenter when a reaction occurs: - Inversion: configuration flips ((R) → (S)). - Retention: configuration stays. - Racemization: configuration is lost; mixture of (R) and (S).

3. Concerted mechanisms (one step, defined geometry) give stereospecific outcomes: - SN2: backside attack → inversion. - E2: anti-periplanar geometry → defined product geometry. - Diels-Alder: concerted [4+2] → syn cis product, stereospecific. - Hydroboration: cyclic 4-membered TS → syn addition.

4. Stepwise mechanisms with planar intermediates (carbocations, free radicals) give racemized outcomes: - SN1: planar carbocation → ~50:50 R/S product. - E1: planar carbocation → may give either E/Z alkene (often Zaitsev). - Radical reactions: planar radical → racemic.

5. Addition reactions are syn or anti depending on mechanism: - Syn: both groups same face. Cyclic TS or surface delivery (OsO₄, hydroboration, hydrogenation, Sharpless epoxidation). - Anti: groups opposite faces. Cyclic intermediate opened by back-side attack (bromonium, epoxide).

6. Prochirality: a planar sp² C (carbonyl, alkene) has two distinguishable faces: - re face: CIP priorities go clockwise when viewed from one side. - si face: CIP priorities go clockwise when viewed from the opposite side. - Attack on different faces gives different enantiomers/diastereomers.

7. Enantiotopic vs diastereotopic protons (or faces): - Enantiotopic: equivalent in achiral environment; distinguishable by chiral environment (chiral reagent, NMR with chiral shift reagent). - Diastereotopic: distinguishable even in achiral environment (different rate of reaction; different NMR signals).

8. Stereospecific vs stereoselective: - Stereospecific: different stereoisomers of substrate give different products (mechanism-mandated). - Stereoselective: a single substrate gives one stereoisomer preferentially over another (kinetic preference). - Stereospecific is a stronger claim.

9. Asymmetric synthesis: use a chiral catalyst (or chiral auxiliary) to selectively make one enantiomer from achiral or prochiral substrate. The catalyst makes one TS lower in energy than the other.

10. Major asymmetric methods (covered in detail in later chapters):

    • Knowles asymmetric hydrogenation with chiral phosphine + Rh.
    • Noyori asymmetric hydrogenation with BINAP-Ru (especially β-keto esters).
    • Sharpless asymmetric epoxidation of allylic alcohols (Ch 8 case study 2).
    • Sharpless asymmetric dihydroxylation with OsO₄ + cinchona ligand.
    • Jacobsen-Katsuki asymmetric epoxidation with Mn-salen.
    • Asymmetric organocatalysis with proline or MacMillan's imidazolidinone (Nobel 2021).
    • Biocatalysis with engineered enzymes.

11. Kinetic resolution: a chiral catalyst reacts with one enantiomer of a racemate faster than the other; stop midway, and the unreactive enantiomer is enriched.

12. Dynamic kinetic resolution (DKR): kinetic resolution + racemization → 100% theoretical yield of one enantiomer.

13. Diastereoselectivity in carbonyl additions:

    • Felkin-Anh model for chiral α-substituted aldehydes/ketones.
    • Cram chelation model for substrates with α-coordinating groups (OH, OR).

14. Drug metabolism is stereochemistry-sensitive:

    • (R)-ibuprofen → (S)-ibuprofen via chiral inversion enzyme (in vivo upgrade).
    • (R)-thalidomide racemizes in vivo via α-enolization.
    • (R)-naproxen is hepatotoxic; sold as pure (S).
    • Methorphan enantiomers: different uses (cough suppressant vs opioid analgesic).
    • Chiral switching (omeprazole → esomeprazole) for patent extension.

15. The thalidomide story is mechanistically understandable: α-carbon stereolability via enolization → racemization → recreation of teratogenic (S). Pure (R) dose is not safe.

16. Stereochemistry tour through the rest of the book:

    • SN2 → inversion (Ch 10).
    • SN1 → racemization (Ch 11).
    • E2 → anti-periplanar (Ch 12).
    • Markovnikov HX, Br₂ → anti (Ch 15-16).
    • Hydroboration, OsO₄, hydrogenation → syn (Ch 16).
    • Diels-Alder → stereospecific syn (Ch 19).
    • Carbonyl additions → Felkin-Anh diastereoselectivity (Ch 25).
    • Aldol → syn or anti depending on enolate (Ch 28).
    • Asymmetric methods → enantioselective (Ch 36, 37).

17. Mastery of Chapter 8 gives you predictive power across all of Chs 10-37. Once you classify a reaction by its mechanism (concerted vs stepwise; cyclic intermediate vs planar; chiral vs achiral catalyst), you can predict its stereochemistry.

18. The mechanism-first thesis is on display here: instead of memorizing a list of reaction stereochemistries, you derive them from a small number of mechanistic principles.

19. Industrial relevance: every chiral drug is the result of a careful asymmetric synthesis (or resolution). Modern process chemistry is built on the principles of Chapter 8.

20. Spectroscopy connection: NMR (Ch 9) directly probes stereochemistry through coupling constants, NOE effects, and chiral shift reagents.

Cross-references

• Chapter 5 — Conformations (anti-periplanar arguments).
• Chapter 7 — Static stereochemistry (foundation).
• Chapter 9 — NMR (coupling constants, NOE, chiral shift).
• Chapter 10 — SN2 (inversion).
• Chapter 11 — SN1 (racemization).
• Chapter 12 — E2 (anti-periplanar).
• Chapter 15-17 — Addition reactions (syn/anti).
• Chapter 19 — Diels-Alder (stereospecific syn).
• Chapter 25 — Felkin-Anh, Cram models.
• Chapter 27 — α-carbon enolization (racemization mechanism).
• Chapter 35 — Drug design (chirality and pharmacology).
• Chapter 36 — Asymmetric oxidation/reduction.
• Chapter 37 — Asymmetric organometallic catalysis.
• Appendix C — Reaction summary.

Study tip

For every reaction you encounter: 1. Classify the mechanism: concerted or stepwise? 2. Identify the intermediate (if any): planar or chiral? 3. Predict stereochemistry: - Concerted, defined geometry → stereospecific (inversion or syn or anti). - Stepwise, planar intermediate → racemization. 4. Check observation: does observed stereochemistry match the predicted mechanism?

The habit to leave with: When you see a reaction at a stereocenter, immediately ask "concerted or stepwise?" If concerted, the stereochemistry is predictable. If stepwise with planar intermediate, expect racemization. This habit unifies all of Part III, IV, V, and VI.

Chapter 9 — NMR — uses stereochemistry directly: coupling constants depend on dihedral angles, and 2D NMR techniques distinguish diastereomers. The R/S work of Chapter 7 and the mechanism work of Chapter 8 both show up in NMR analysis.